PMGC (ELAB) Stock: Buy, Sell, or Hold?
$1.59
+0.01 (+0.63%)
▲
5d:
-3.64%
30d:
-46.46%
90d:
+74.73%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
50/100
Position
OVERSOLD
30-Day Fair Range
$2.09 – $3.15
Position: OVERSOLD
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$1.41 / $2.70
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ELAB shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ELAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ELAB is currently trading at $1.59, which is considered oversold relative to its 30-day fair value range of $2.09 to $3.15.
Technical Outlook: Technically, ELAB is in a downtrend. Immediate support is located at $1.41, while resistance sits at $2.70.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELAB is in a downtrend. Immediate support is located at $1.41, while resistance sits at $2.70.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.09 -
$3.15
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
74.7%
Trading Range & Key Levels
30-Day Trading Range
$2.09 -
$3.15
Current vs Trading Range
OVERSOLD
Support Level
$1.41
Resistance Level
$2.70
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Revenue Growth (YoY)
-45.8%
Share ELAB Analysis
Share this live ELAB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ELAB)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user shares their success in buying dips in $ELAB stock and encourages others to join a free group of bulls.
Key Retail Themes:
Buy the dip strategy
Positive sentiment towards $ELAB
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:24 PM ET
Data refreshes hourly during market hours. Next update: 10:24 PM
Data refreshes hourly during market hours. Next update: 10:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 48 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ELAB Research Pages
